| 000 | 01753 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515020218.0 | ||
| 264 | 0 | _c20070104 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1093/annonc/mdl045 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArdine, M | |
| 245 | 0 | 0 |
_aCould the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw? _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cAug 2006 |
||
| 300 |
_a1336-7 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadverse effects |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aBreast Neoplasms _xpathology |
| 650 | 0 | 4 |
_aCalcium _xblood |
| 650 | 0 | 4 |
_aDiphosphonates _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJaw Diseases _xchemically induced |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteonecrosis _xchemically induced |
| 650 | 0 | 4 |
_aParathyroid Hormone _xblood |
| 700 | 1 | _aGenerali, D | |
| 700 | 1 | _aDonadio, M | |
| 700 | 1 | _aBonardi, S | |
| 700 | 1 | _aScoletta, M | |
| 700 | 1 | _aVandone, A M | |
| 700 | 1 | _aMozzati, M | |
| 700 | 1 | _aBertetto, O | |
| 700 | 1 | _aBottini, A | |
| 700 | 1 | _aDogliotti, L | |
| 700 | 1 | _aBerruti, A | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 17 _gno. 8 _gp. 1336-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdl045 _zAvailable from publisher's website |
| 999 |
_c16134447 _d16134447 |
||